UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
We review which stablecoins fall under regulatory scrutiny, the regimes that apply, and practical implications for users and providers alike.
19,598 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
ThredUp's chief argues that a permanent four-day workweek provides a competitive edge in attracting talent. The broad...
When prices surge, some firms enjoy sudden profits. This piece explains why the corporate income tax already taxes th...
In a year of volatile rates, Vanguard’s cheapest short-term bond ETF stands out for ultra-low fees and solid near-ter...
Private-market buyers are circling Anthropic as rumors of a massive follow-on round surface, pushing a volatile priva...
Zoom stock jumped today as investors priced in AI-driven growth and expanding enterprise traction. This article break...
Eating out is a daily ritual for many families. This guide shows you how to choose credit card dining rewards that ac...
Investors often ask whether Netflix has the widest moat in streaming. This deep dive breaks down the moat components,...
Imagine Micron topping a trillion-dollar market cap. The market would react in unpredictable ways. This guide explain...
European banks are delivering surprising gains in 2026, challenging U.S. rivals. This guide breaks down why the trend...
Pi Network is in a renewed pullback, with the price slipping toward $0.13 after failing to sustain a bounce above $0....
Meta Platforms is navigating a bold AI infrastructure push that could redefine profits. This guide breaks down the ri...